These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 2507775)
21. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers. Meisheri KD; Khan SA; Martin JL J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468 [TBL] [Abstract][Full Text] [Related]
22. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers. Fabiani ME; Vlahos R; Story DF Pharmacol Res; 1996; 33(4-5):261-72. PubMed ID: 8938019 [TBL] [Abstract][Full Text] [Related]
23. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium. Lau WM Pharmacology; 1992; 45(1):9-16. PubMed ID: 1508969 [TBL] [Abstract][Full Text] [Related]
24. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury. Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506 [TBL] [Abstract][Full Text] [Related]
25. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries. Nielsen-Kudsk JE Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816 [TBL] [Abstract][Full Text] [Related]
26. ATP-sensitive potassium channels and skeletal muscle function in vitro. Weselcouch EO; Sargent C; Wilde MW; Smith MA J Pharmacol Exp Ther; 1993 Oct; 267(1):410-6. PubMed ID: 8229769 [TBL] [Abstract][Full Text] [Related]
27. The inhibitory effects of cromakalim and its active enantiomer BRL 38227 against various agonists in guinea pig and human airways: comparison with pinacidil and verapamil. Taylor SG; Arch JR; Bond J; Buckle DR; Shaw DJ; Taylor JF; Ward JS J Pharmacol Exp Ther; 1992 May; 261(2):429-37. PubMed ID: 1578358 [TBL] [Abstract][Full Text] [Related]
28. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts. Tosaki A; Engelman DT; Engelman RM; Das DK J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071 [TBL] [Abstract][Full Text] [Related]
29. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia. D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295 [TBL] [Abstract][Full Text] [Related]
30. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts]. Taki H; Masuda Y; Yoshizumi M; Kitagawa T; Katoh I Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573 [TBL] [Abstract][Full Text] [Related]
31. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. Cavero I; Mondot S; Mestre M J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353 [TBL] [Abstract][Full Text] [Related]
32. Comparative relaxant effects of cromakalim and pinacidil on the tonic contraction of canine coronary artery induced by phorbol 12,13-dibutylate. Kuromaru O; Sakai K Clin Exp Pharmacol Physiol; 1996; 23(6-7):493-7. PubMed ID: 8800572 [TBL] [Abstract][Full Text] [Related]
33. Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. Wolleben CD; Sanguinetti MC; Siegl PK J Mol Cell Cardiol; 1989 Aug; 21(8):783-8. PubMed ID: 2506353 [TBL] [Abstract][Full Text] [Related]
34. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. McPherson GA; Angus JA Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201 [TBL] [Abstract][Full Text] [Related]
35. Cromakalim, RP49356, pinacidil and minoxidil sulphate in the rat uterus and their antagonism by glibenclamide. Smooth Muscle Research Group. Piper I; Hollingsworth M Br J Pharmacol; 1989 Dec; 98 Suppl():807P. PubMed ID: 2514955 [No Abstract] [Full Text] [Related]
36. Specific antagonism by glibenclamide of negative inotropic effects of potassium channel openers in canine atrial muscle. Satoh E; Yanagisawa T; Taira N Jpn J Pharmacol; 1990 Oct; 54(2):133-41. PubMed ID: 2150209 [TBL] [Abstract][Full Text] [Related]
37. Inhibitors of nitric oxide synthesis and ischemia/reperfusion attenuate coronary vasodilator response to pinacidil in isolated rat heart. Maczewski M; Beresewicz A J Physiol Pharmacol; 1997 Dec; 48(4):737-49. PubMed ID: 9444621 [TBL] [Abstract][Full Text] [Related]
38. Effects of several potassium channel openers and glibenclamide on the uterus of the rat. Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195 [TBL] [Abstract][Full Text] [Related]
39. Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660. Buckle DR; Arch JR; Bowring NE; Foster KA; Taylor JF; Taylor SG; Shaw DJ Pulm Pharmacol; 1993 Mar; 6(1):77-86. PubMed ID: 8477155 [TBL] [Abstract][Full Text] [Related]
40. Effects of the K+ channel activators, RP 52891, cromakalim and diazoxide, on the plasma insulin level, plasma renin activity and blood pressure in rats. Pratz J; Mondot S; Montier F; Cavero I J Pharmacol Exp Ther; 1991 Jul; 258(1):216-22. PubMed ID: 1906538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]